National Plaque Registry and Database (OPeRA)

April 24, 2017 updated by: Pál Maurovich-Horvat, Semmelweis University Heart and Vascular Center

The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome. Early identification of vulnerable plaques may have an enormous impact on public health through primary and secondary prevention of acute myocardial infarction.

Investigators hypothesize that a risk score that incorporates non-invasive coronary CT imaging (calcium score and/or coronary CTA) in combination with clinical characteristics (classical risk prediction models) will improve the identification of patients who are at highest risk to suffer myocardial infarction or sudden cardiac death.

The overall goal of the OPeRA project is to develop, implement and validate a novel risk assessment tool based on image markers and clinical characteristics to identify patients who are at increased risk to suffer myocardial infarction or sudden cardiac death.

Study Overview

Status

Not yet recruiting

Detailed Description

The primary goals of OPeRA consortium:

To develop a national coronary CTA registry with the collaboration of all major cardiac CT centers of Hungary (Országos Plaque Regiszter és Adatbázis - NatiOnal Plaque Registry and DAtabase, OPeRA).

  1. To develop a novel risk assessment tool (OPeRA score) based on image markers and clinical characteristics.
  2. To identify and validate novel vulnerable coronary plaque image markers and assess their prognostic value.

Secondary goals:

  1. To develop a standardized and structured, national coronary CTA reporting system.
  2. To establish a national quality control system that monitors the quantity of iodinated contrast agent and the patients' radiation dose.

Study Type

Observational

Enrollment (Anticipated)

20000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Klaudia Bikov
  • Phone Number: +36208256889
  • Email: office@cirg.hu

Study Locations

      • Budapest, Hungary, 1117
        • Pozitron Diagnostic Center
    • Baranya
      • Pécs, Baranya, Hungary, 7624
        • University of Pécs
    • Borsod-Abaúj-Zenpén
      • Miskolc, Borsod-Abaúj-Zenpén, Hungary, 3526
        • Borsod-Abaúj-Zemplén County Hospital and Teaching Hospital
    • Békés
      • Gyula, Békés, Hungary, 5700
        • Pándy Kálmán County Hospital
    • Csongrád
      • Szeged, Csongrád, Hungary, 6725
        • University of Szeged
    • Győr-Moson-Sopron
      • Győr, Győr-Moson-Sopron, Hungary, 9023
        • Petz Aladár County Teaching Hospital
    • Hajdú-Bihar
      • Debrecen, Hajdú-Bihar, Hungary, 4032
        • University of Debrecen
    • Heves
      • Eger, Heves, Hungary, 3300
        • Markhot Ferenc Teaching Hospital and Clinic
    • Pest
      • Budapest, Pest, Hungary, 1134
        • Homeland Defence Hospital
    • Somogy
      • Kaposvár, Somogy, Hungary, 7400
        • Health Centrum, Kaposvár University
    • Vas
      • Szombathely, Vas, Hungary, 9700
        • Markusovszky Teaching Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients who underwent clinically indicated coronary CTA are involved in the sudy.

Description

Inclusion Criteria:

  • Age > 18 years
  • Subject providing written informed consent
  • Scheduled to undergo a clinically indicated coronary CTA

Exclusion Criteria:

  • Age <18 years
  • Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)
  • Recent prior myocardial infarction within 30 days prior to coronary CTA or between coronary CTA and ICA
  • Pregnancy or unknown pregnancy status in subject of childbearing potential
  • Subject requires an emergent procedure
  • Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure <90 mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema
  • Inability to comply with study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Coronary CT Angiography (CCTA)
Patients included in the OPeRA Registry are those that have previously undergone clinically-indicated CCTA as part of their standard of care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
All cause death
Time Frame: 10 years
10 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Myocardial infarction
Time Frame: 10 years
10 years
Unstable angina
Time Frame: 10 years
10 years
Target vessel revascularization
Time Frame: 10 years
10 years
CAD-related hospitalization
Time Frame: 10 years
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pál Maurovich-Horvat, MD, PhD, MPH, Heart and Vascular Center, Smellweis University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2016

Primary Completion (Anticipated)

December 1, 2030

Study Completion (Anticipated)

December 1, 2030

Study Registration Dates

First Submitted

October 14, 2015

First Submitted That Met QC Criteria

October 15, 2015

First Posted (Estimate)

October 16, 2015

Study Record Updates

Last Update Posted (Actual)

April 25, 2017

Last Update Submitted That Met QC Criteria

April 24, 2017

Last Verified

April 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Subscribe